Related references
Note: Only part of the references are listed.Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19
George Vere et al.
BIOMOLECULES (2022)
Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh et al.
INTESTINAL RESEARCH (2022)
Management of inflammatory bowel disease in the COVID-19 era
Kyeong Ok Kim et al.
INTESTINAL RESEARCH (2022)
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study
Lennard P. L. Gilissen et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2022)
Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience
Vered Richter et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia et al.
ENVIRONMENTAL RESEARCH (2022)
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19
Martina Orlandi et al.
RHEUMATOLOGY (2022)
Multidimensional 3-Month Follow-Up of Severe COVID-19: Airways beyond the Parenchyma in Symptomatic Patients
Matteo Bonato et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
Moein Shirzad et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection
Millie D. Long et al.
CROHNS & COLITIS 360 (2022)
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases
Erica J. Brenner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research
Hiroshi Nakase et al.
DIGESTION (2021)
Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules
Anke L. H. Nguyen et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource
Evangelos Stournaras et al.
GUT (2021)
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Ryan C. Ungaro et al.
GUT (2021)
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid Spain
Ivan Guerra et al.
INFLAMMATORY BOWEL DISEASES (2021)
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
Kristin E. Burke et al.
INFLAMMATORY BOWEL DISEASES (2021)
Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study
Mohamed Attauabi et al.
JOURNAL OF CROHNS & COLITIS (2021)
A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic
Harleen Chela et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study
Cristina Bezzio et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
COVID-19 in IBD: The experience of a single tertiary IBD center
Fernando Rizzello et al.
DIGESTIVE AND LIVER DISEASE (2021)
COVID-19 and IBD drugs: should we change anything at the moment?
Charlie W. Lees et al.
GUT (2021)
Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
Rob H. Creemers et al.
PLOS ONE (2021)
Diagnostics for SARS-CoV-2 infections
Bhavesh D. Kevadiya et al.
NATURE MATERIALS (2021)
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk et al.
NATURE COMMUNICATIONS (2021)
Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
Keiichi Tominaga et al.
FRONTIERS IN PHARMACOLOGY (2021)
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
Caleb D. Swaim et al.
ISCIENCE (2021)
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician
Julio Maria Fonseca Chebli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey
Natalia Sousa Freitas Queiroz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
Irwin Jungreis et al.
NATURE COMMUNICATIONS (2021)
Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis
Qiang Miao et al.
SCIENTIFIC REPORTS (2021)
Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy Experience
Naire Sansotta et al.
FRONTIERS IN PEDIATRICS (2021)
Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study
Antoine Meyer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
Narinder Grover et al.
BMC GASTROENTEROLOGY (2021)
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
Laura E Targownik et al.
Journal of the Canadian Association of Gastroenterology (2021)
COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry
Natalia S. F. Queiroz et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection
Marina Saresella et al.
MOLECULAR NEUROBIOLOGY (2021)
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
Margalida Calafat et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD
Christian Philipp Selinger et al.
BMJ OPEN GASTROENTEROLOGY (2021)
Care of inflammatory bowel disease patients during coronavirus disease-19 pandemic using digital health-care technology
Uday C. Ghoshal et al.
JGH OPEN (2021)
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain
Ivan Guerra et al.
INFLAMMATORY BOWEL DISEASES (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
COVID-19: a new challenge for human beings
Penghui Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
Mariangela Allocca et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
John Gubatan et al.
GASTROENTEROLOGY (2020)
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)
Iago Rodriguez-Lago et al.
GASTROENTEROLOGY (2020)
Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy
Lorenzo Norsa et al.
GASTROENTEROLOGY (2020)
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
David T. Rubin et al.
GASTROENTEROLOGY (2020)
Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2020)
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
Cristina Bezzio et al.
GUT (2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A. Kennedy et al.
GUT (2020)
Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature
Melissa H. Rosen et al.
INFLAMMATORY BOWEL DISEASES (2020)
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce
F. Magro et al.
JOURNAL OF CROHNS & COLITIS (2020)
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
Lucy van Dorp et al.
INFECTION GENETICS AND EVOLUTION (2020)
Inflammatory Bowel Disease - Non-biological treatment
Fernando Magro et al.
PHARMACOLOGICAL RESEARCH (2020)
Characterization of accessory genes in coronavirus genomes
Christian Jean Michel et al.
VIROLOGY JOURNAL (2020)
Immunosuppressive Drugs and COVID-19: A Review
Tessa S. Schoot et al.
FRONTIERS IN PHARMACOLOGY (2020)
Gastrointestinal insights during the COVID-19 epidemic
Kai Nie et al.
WORLD JOURNAL OF CLINICAL CASES (2020)
Immunotherapeutic approaches to curtail COVID-19
Hajar Owji et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
Fabio Salvatore Macaluso et al.
DIGESTIVE AND LIVER DISEASE (2020)
Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic
Khoon Lin Ling et al.
JGH OPEN (2020)
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Jean-Frederic Colombel et al.
JOURNAL OF CROHNS & COLITIS (2020)
Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease
Shan-Shan Gong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience
Cristina Suarez Ferrer et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
Sheng Zhang Lim et al.
FRONTIERS IN PHARMACOLOGY (2018)
Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
Prashanth Rawla et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Optimising use of thiopurines in inflammatory bowel disease
Robin J. Dart et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease
Raja Atreya et al.
VISCERAL MEDICINE (2017)
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
Jordan E. Axelrad et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
Kai-Wen Cheng et al.
ANTIVIRAL RESEARCH (2015)
Clinical predictors of thiopurine-related adverse events in Crohn's disease
Gordon W. Moran et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Optimizing the use of thiopurines in inflammatory bowel disease
Rishi M. Goel et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
Jian Lei et al.
ANTIVIRAL RESEARCH (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Opportunistic Infections Due to Inflammatory Bowel Disease Therapy
Maneesh Dave et al.
INFLAMMATORY BOWEL DISEASES (2014)
Immunosuppressive therapies for inflammatory bowel disease
Talia Zenlea et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-dependent Crohn's Disease
Gerassimos J. Mantzaris et al.
INFLAMMATORY BOWEL DISEASES (2009)
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
Chi-Yuan Chou et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity
N Barretto et al.
JOURNAL OF VIROLOGY (2005)